Search

Phylogica sinks on licensing setback

Shares in Subiaco-based biotech firm Phylogica have plummeted on the ASX after a potential licensing deal with a subsidiary of pharmaceutical giant Johnson & Johnson effectively collapsed.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Sign up for free emails

Complete your details below to receive our twice-daily news emails and our BN Weekender.

CAPTCHA
Thanks! This question prevents spammers...
Image CAPTCHA
Enter the characters shown in the image.

Add your comment

Phylogica (PYC)

Share Price

Closing price for the last 90 trading days
Source: Morningstar

Total Shareholder Return as at 31/01/18

1 year TSR5 year TSR
424thPhylogica6%11%
498thAlterra-6%-11%
546thAlgae.Tec-15%-30%
700thNuheara-41%-9%
789thRewardle Holdings-64%0%
709 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

04/01/18
$0 Issued
04/01/18
$0 Other
29/11/17
$56k Issued
Total value as at the date of the transaction
Source: Morningstar

Revenue

111th↑Nuheara$2.9m
112th↓Algae.Tec$2.8m
113th↑Phylogica$2.8m
114th↓Alterra$2.7m
115th↓Rewardle Holdings$2.6m
234 listed industrial companies ranked by revenue.
Source: Morningstar

Remuneration from Phylogica

1361stBernard Hockings$44k
1527thStephanie Unwin$26k
Ranked by total remuneration from all listed WA companies

BNiQ Disclaimer